Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Pharmaceuticals & Biotechnology Royalty Rates Report 2022 with Theory Associated with Deriving Royalty Rates


DUBLIN, May 23, 2022 /PRNewswire/ -- The "Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Royalty Rates for Pharmaceuticals & Biotechnology features more real-deal royalty rates, license fees, and milestone payment benchmarks than any other publication.

The ninth edition of Royalty Rates for Pharmaceuticals & Biotechnology contains hundreds of royalty rates and other financial compensation benchmarks that can be used to optimize the pricing of biotechnology and pharmaceutical innovations. You'll find updated and expanded information from past editions as well as an increased number of reported license agreements.

This new edition and the transaction details have been collected from well-established sources over a period of 22 years of research. Royalty Rates for Pharmaceuticals & Biotechnology provides real-deal information for hundreds of transactions, including the technology licensed, royalty rates, license fees, and milestone payments. And it goes well beyond the rates to provide context for each deal analyzed.

This unique resource is organized into two useful sections:

The first section covers the theory associated with deriving royalty rates.

An overview of intellectual property value is included along with seven methods that can be employed to derive royalty rates: Simple Rules of Thumb, Industry Guidelines, Discounted Cash Flow Analysis, Risk-Adjusted Net Present Value Analysis, Infringement Damages Analysis, Comparable License Transactions, Investment Rate of Return Analysis, and the Relief-From-Royalty Method.

The second section of this one-of-a-kind report presents detailed financial information from real-world transactions. 

You'll find information on the parties involved in the transactions along with a description of the technology exchanged and all financial details that could be discovered. This publication is designed to provide accurate and authoritative information about the subject matter covered. 

Key Topics Covered:

For more information about this report visit https://www.researchandmarkets.com/r/7fm5y6

Media Contact:

Research and Markets 
Laura Wood, Senior Manager 
[email protected] 

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630 
For GMT Office Hours Call +353-1-416-8900 

U.S. Fax: 646-607-1907 
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 20:37
In advance of the July 4th Independence Day weekend, the American Association of Kidney Patients (AAKP), the nation's largest independent kidney patient organization, released their annual summer reading list featuring articles by AAKP-affiliated...

at 20:20
From a cold, wet spring that forced a late planting to June storms that left many Midwestern farmers assessing hail damage, the 2022 growing season got off to a bumpy start across much of the Corn Belt. Fortunately, farmers are resilient by nature,...

at 20:13
Carebook Technologies Inc. ("Carebook" or the "Company") (XETR: PMM1), a leading Canadian provider of innovative digital health solutions, today announced the voting results from the Annual General and Special Meeting of its Shareholders held...

at 19:23
Pharmacy benefit manager (PBM) Prime Therapeutics' proposed acquisition of rival PBM Magellan Rx Management "raises serious anti-competitive concerns" and should be blocked, according to a letter sent today from American Pharmacy Cooperative, Inc....

at 19:08
BIOLASE, Inc. , the global leader in dental lasers, announced that, on June 30, 2022, it entered into an amendment to its senior secured term loan with SWK Funding LLC. The amendment extends the interest-only period of the loan by two quarters to...

at 19:04
NVISION® Eye Centers is pleased to announce the addition of two retina practices to the NVISION family ? Salt Lake Retina in Salt Lake City, UT and Retina Associates of Southern California in Los Angeles and Orange County, California....



News published on 23 may 2022 at 08:15 and distributed by: